Table 1 Number of patients receiving VA therapy
Total | Female | Male | ||||
|---|---|---|---|---|---|---|
VA therapy in general | 176 | 73.3 % | 93 | 75.0 % | 83 | 71.6 % |
Subcutaneous total | 157 | 89.2 % | 82 | 88.2 % | 75 | 90.4 % |
Intravenous total | 62 | 35.2 % | 32 | 34.4 % | 30 | 36.1 % |
Intratumoral total | 34 | 19.3 % | 13 | 14.0 % | 21 | 24.4 % |
Other total | 4 | 2.2 % | 3 | 3.2 % | 1 | 1.2 % |
Subcutaneous only | 93 | 52.8 % | 55 | 59.1 % | 38 | 45.8 % |
Intravenous only | 6 | 3.4 % | 5 | 5.4 % | 1 | 1.2 % |
Intratumoral only | 6 | 3.4 % | 2 | 2.2 % | 4 | 4.8 % |
Subcutaneous/intravenous | 38 | 21.6 % | 17 | 18.3 % | 21 | 25.3 % |
Subcutaneous/intratumoral | 10 | 5.7 % | 1 | 1.1 % | 9 | 10.8 % |
Intravenous/intratumoral | 1 | 0.6 % | 1 | 1.2 % | ||
Subcutaneous/intravenous/intratumoral | 15 | 8.5 % | 8 | 8.6 % | 7 | 8.4 % |